AQST | Aquestive Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	50.58M	47.68M	50.83M	45.85M	52.61M	67.43M	66.92M	51.78M
Cost of Revenue	20.83M	19.39M	14.99M	12.96M	20.36M	20.99M	19.82M	16.38M
Gross Profit	29.75M	28.29M	35.84M	32.88M	32.25M	46.44M	47.10M	35.41M
Operating Expenses	44.85M	70.36M	70.52M	75.78M	84.92M	95.38M	47.21M	36.25M
Selling, General & Admin	31.75M	52.88M	53.48M	55.89M	64.34M	72.26M	25.08M	20.80M
Research & Development	13.10M	17.48M	17.05M	19.89M	20.57M	23.11M	22.13M	15.45M
Other Operating Expenses	N/A	N/A	N/A	N/A	N/A	-5.00K	N/A	-99.00K
Operating Income	-15.10M	-42.07M	-34.68M	-42.89M	-52.67M	-48.93M	-113.00K	-847.00K
Other Expenses / Income	7.48M	-12.34M	-35.86M	-12.89M	-13.58M	-12.44M	-8.83M	-8.76M
Before Tax Income	-7.62M	-54.41M	-70.54M	-55.78M	-66.25M	-61.38M	-8.94M	-9.60M
Income Tax Expenses	245.00K	5.79M	19.50M	9.58M	6.41M	-4.73M	7.71M	6.04M
Net Income	-7.87M	-60.20M	-90.04M	-65.36M	-72.66M	-61.38M	-8.94M	-9.60M
Interest Expenses	7.46M	12.44M	22.46M	13.02M	9.32M	7.71M	7.71M	6.14M
Basic Shares Outstanding	61.26M	48.73M	38.08M	33.65M	25.36M	20.73M	20.00M	24.50M
Diluted Shares Outstanding	61.26M	48.73M	38.08M	33.65M	25.36M	20.73M	20.00M	24.50M
EBITDA	1.18M	-39.58M	-45.11M	-39.15M	-53.88M	-50.33M	2.56M	2.94M
EBITDA Margin	2.34%	-83.01%	-88.75%	-85.40%	-102.41%	-74.63%	3.83%	5.69%
EBIT	-163.00K	-41.97M	-48.08M	-42.76M	-56.93M	-58.40M	6.47M	2.58M
EBIT Margin	-0.32%	-88.02%	-94.58%	-93.26%	-108.21%	-86.60%	9.67%	4.99%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31